CLINICAL ROLE -
Revised Clinical Trial Program to Evaluate Daily Oral Islatravir Plus Doravirine Combo for HIV-1
Revised program will analyze the once-daily oral combination of doravirine 100 mg and a lower dose of islatravir in adults with HIV-1 infection.
Read More
Study: Racial Disparities in Outcome of Neoadjuvant Endocrine Therapy for HR-Positive Breast Cancer Patients
Black women are suggested to be diagnosed with stage 3 HR-positive breast cancer and receive longer neoadjuvant endocrine therapy more often than White women.
Study: Mediterranean Diet Positively Associated with Cognitive Function
Changing one’s diet could change brain health and study results suggest the Mediterranean diet could positively support cognitive function.
Study: Moderate Dairy Consumption Could Decrease Risk of Type 2 Diabetes
New research suggests that 200 g/day of milk can reduce the risk of type 2 diabetes by 10%.
Imfinzi Plus Chemotherapy Shows Positive Results for Advanced Biliary Tract Cancer
Phase 3 TOPAZ-1 trial of AstraZeneca’s durvalumab demonstrates an improved overall survival benefit.
Olaparib With or Without Bevacizumab Shows Positive Results as Ovarian Cancer Treatment
AstraZeneca’s Lynparza in combination or as a monotherapy demonstrates meaningful survival benefit in long-term follow-up.
California Modifies End of Life Option Act
Amendments reflecting more contemporary options could raise ethical questions for health care workers.
Ultra-Processed Foods Found to Increase Colorectal Cancer Risk in Men
Study indicates that a diet high in ultra-processed food is more likely to increase the risk of colorectal cancer in men than it is women.
Study: Medical Cannabis May Have Far-Reaching Benefits for Neurological Disorders
Research suggests cannabis can improve quality of life for patients who suffer from pain and neurological disorders.
Glaucoma Treatment Shows Positive Results in Phase 3 Trial
Researchers will submit a new drug application to the FDA after a phase 3 trial found that iDose TR slow- and fast-release models met their primary endpoint in patients with glaucoma.
Pharmacy Leaders Can Establish Successful 503B Relationships
Key questions to ask when deciding whether compounding facilities are the right fit.
More Than Prescriptions: What Beginning Pharmacists Need to Know About Business
Pharmacists should get involved in all the various aspects of their business and with the different professional groups available.
New NIH Program Funds Efforts to Improve Gender Equity in Science, Health Care Fields
GENDER R25 will provide funding for courses and curricula to improve gender-focused education and equity in pharmacy, as well as other health care fields.
Unique Offerings, Curriculum to Prepare for Cultural Differences
The most important thing you must do is listen to the patient, understand their concerns, and by doing that, you will gain their trust to be able to treat them appropriately.
Watch
Older Adults With Herpes Zoster Have Unique Considerations
Pharmacists can educate older adults on risk factors and prevention efforts around herpes zoster.
How Stakeholders Can Maximize the Value of Real-World Data Analytics
Analytics allow for a better understanding of the needs of various patient populations and the barriers they face in accessing care.
Options for Immunoglobulin Administration Allow for Personalized Treatment of Chronic Inflammatory Demyelinating Polyneuropathy
Although there is no “best” way to determine which route of administration is best, health care providers are optimally positioned to educate patients and help them make the best decision.
Study: 1 in 4 Families of Children With Acute Lymphoblastic Leukemia Face Food Insecurity
Receiving benefits from the SNAP program does not alleviate the issue, according to the analysis.
Study: Patients With Cancer Lack Access to LGBTQI+-Tailored Education Material
Analysis shows that individuals who are comfortable sharing their identities with providers are more likely to be satisfied with overall care.
Consumers Overpay for Generic Alternatives, Study Results Show
USC Analysis: although generics save US health care systems billions, PBMs jack up prices for employers, government, and patients.
Phase 3 Study Initiated for Pfizer mRNA-Based Influenza Vaccine
Quadrivalent mRNA influenza vaccine candidate to be evaluated in approximately 25,000 healthy US adults.
New NCCN Patient Guidelines for Marginal Zone Lymphoma Helps Patients, Caregivers Understand Rare Form of Blood Cancer
Management of marginal zone lymphoma was impacted by the COVID-19 pandemic because some treatment options can reduce B-cell-produced antibodies.
Pharmacist Insights: Migraine Medications
Migraines are multifactorial and patient-specific, causing accessible care and treatments to be limited and ignored.
Sugammadex: Use Criteria Optimization and Outcomes Data Evaluation
Establishing new use criteria led to an 86% reduction in the utilization of sugammadex with no appreciable impact on measured outcomes.
Nasal Self-Sampling Rapid Antigen COVID-19 Test Performance May Have Decreased Over Time
While the performance of nasal self-sampling rapid antigen tests for COVID-19 was found to decrease over time, adding oropharyngeal may improve its performance.
Low Testosterone in Men May be a Risk Factor for Hospitalization from COVID-19
Men with chronically low testosterone levels are more likely to be hospitalized from COVID-19 than those with normal levels, but testosterone therapy could decrease this risk.
Immune Thrombocytopenia Purpura Treatment Options Abound
Corticosteroids are first-line therapy for gaining platelet stability but should only be used short term.
Study: Online Communities Can Provide Lifeline for Patients in Remission from Opioid Use Disorder
Online communities can help opioid users in remission maintain long-lasting sobriety, however the research suggests these communities should be non-drug-related.
Pharmacy Care Coaches Improve Outcomes in Patients With Diabetes
Care Coach program offers a comprehensive set of pharmacy and counseling services to patients struggling to manage their diabetes.
Novel Treatment Shows Promise, Manageable Safety in MCL, CLL
NVG-111 is a humanized, tandem single-chain variable fragment ROR1 x CD3 BiTE being evaluated in relapsed/refractory chronic lymphocytic leukemia and mantle cell lymphoma.